10-Q quarterly report · filed Oct 30, 2026

Core Laboratories Inc. /DE/ (CLB) Q3 2026 10-Q Quarterly Report

Short answer

Core Laboratories Inc. /DE/ (CLB) filed its Q3 2026 10-Q quarterly report on Oct 30, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $132M (down 1.8% year over year) with net income of $5M.

Q3 2026 key financials · XBRL

Revenue
$132M
−1.8% YoY · +6.0% QoQ
Net income
$5M
−61.8% YoY · −8.6% QoQ
Operating margin
9.1%
EPS (diluted)
$0.12
−60.0% YoY · −7.7% QoQ

Source: XBRL data from the Core Laboratories Inc. /DE/ (CLB) Q3 2026 10-Q on SEC EDGAR. USD.

Core Laboratories Inc. /DE/ Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $132.1M, down 2% YoY from $134.5M
  • Net income $5.5M, 4% margin vs 11% YoY; operating margin 9% vs 16%
  • Best segment: Production Enhancement revenue $47.8M, up 3%, margin 9%; Reservoir Description revenue $84.3M, down 4%, margin 9% vs 19%
  • Cash $21.4M vs $22.7M at December 31, 2025; operating cash flow $16.7M for nine months vs $29.1M
  • Capital deployment: $14.4M capital expenditures, $7.7M share repurchases, $1.4M dividends; geopolitical conflicts and sanctions driving near-term volatility

Risk Factors

  • No material changes disclosed from the December 31, 2025 Form 10-K risk factors
  • Business performance risk: known or unknown risks could materially affect operations, financial position, or results
  • Information risk: currently immaterial or unknown risks may impair business operations

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Core Laboratories Inc. /DE/ quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.